Late altered organ function in very long-term survivors after allogeneic hematopoietic stem cell transplantation: A paired comparison with their HLA-identical sibling donor

Haematologica

Volumn 96, Issue 1, 2011, Pages 150-155

  Rovó, Alicia ^a   Daikeler, Thomas ^a   Halter, Jörg ^a   Heim, Dominik ^a   Tsakiris, Dimitrios A ^a   Stern, Martin ^a   Waltimo, Tuomas ^b   Studt, Jan Dirk ^a   Tyndall, Alan ^a   Gratwohl, Alois ^a   Tichelli, André ^a  

^a Section of Dental Medicine   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Late effects; Stem cell transplantation

Indexed keywords

ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; VON WILLEBRAND FACTOR;

ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CARDIOVASCULAR RISK; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CIGARETTE SMOKING; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; DYSLIPIDEMIA; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HEALTH STATUS; HEMATOLOGIC MALIGNANCY; HLA MATCHING; HUMAN; HUMAN CELL; HYPERTENSION; INFLAMMATION; LABORATORY TEST; LIVER FUNCTION TEST; LIVING DONOR; MALE; NORMAL VALUE; SIBLING; SURVIVAL TIME; SURVIVOR; SYSTEMIC DISEASE; THERAPY EFFECT; THYROID DISEASE;

ADOLESCENT; ADULT; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA ANTIGENS; HUMANS; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; RISK FACTORS; SIBLINGS; SURVIVAL RATE; SURVIVORS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 78650973582     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2010.030874     Document Type: Article

References (33)

1. Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med. 2006;354 (17):1813-26.
2. Gratwohl A, Baldomero H, Aljurf M, Pasquini MC, Bouzas LF, Yoshimi A, et al. Hematopoietic stem cell transplantation: a global perspective. JAMA. 2010;303(16): 1617-24.
3. Tichelli A, Rovó A, Passweg J, Schwarze CP, Van Lint MT, Arat M, et al. Late complications after hematopoietic stem cell transplantation. Expert Review of Hematology. 2009;2(5):583-601.
4. Gratwohl A, Stern M, Brand R, Apperley J, Baldomero H, de WT, et al. Risk score for outcome after allogeneic hematopoietic stem cell transplantation: a retrospective analysis. Cancer. 2009;115(20):4715-26.
5. Bhatia S, Francisco L, Carter A, Sun CL, Baker KS, Gurney JG, et al. Late mortality after allogeneic hematopoietic cell transplantation and functional status of longterm survivors: report from the Bone Marrow Transplant Survivor Study. Blood. 2007;110(10):3784-92.
6. Friedman DL, Rovo A, Leisenring W, Locasciulli A, Flowers ME, Tichelli A, et al. Increased risk of breast cancer among survivors of allogeneic hematopoietic cell transplantation: a report from the FHCRC and the EBMT-Late Effect Working Party. Blood. 2008;111(2):939-44.
7. Socie G, Curtis RE, Deeg HJ, Sobocinski KA, Filipovich AH, Travis LB, et al. New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia. J Clin Oncol. 2000;18(2):348-57.
8. Rizzo JD, Curtis RE, Socie G, Sobocinski KA, Gilbert E, Landgren O, et al. Solid cancers after allogeneic hematopoietic cell transplantation. Blood. 2009;113(5):1175-83.
9. Belkacemi Y, Labopin M, Vernant JP, Prentice HG, Tichelli A, Schattenberg A, et al. Cataracts after total body irradiation and bone marrow transplantation in patients with acute leukemia in complete remission: a study of the European Group for Blood and Marrow Transplantation. Int J Radiat Oncol Biol Phys. 1998;41(3):659-68.
10. Tichelli A, Gratwohl A, Egger T, Roth J, Prunte A, Nissen C, et al. Cataract Formation after Bone Marrow Transplantation. Annals of Internal Medicine. 1993;119(12):1175-80.
11. Rovo A, Tichelli A, Passweg JR, Heim D, Meyer-Monard S, Holzgreve W, et al. Spermatogenesis in long-term survivors after allogeneic hematopoietic stem cell transplantation is associated with age, time interval since transplantation, and apparently absence of chronic GvHD. Blood. 2006;108(3):1100-5.
12. Salooja N, Szydlo RM, Socie G, Rio B, Chatterjee R, Ljungman P, et al. Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey. Lancet. 2001;358(9278):271-6.
13. Cohen A, Bekassy AN, Gaiero A, Faraci M, Zecca S, Tichelli A, et al. Endocrinological late complications after hematopoietic SCT in children. Bone Marrow Transplant. 2008;41 Suppl 2S43-S48.
14. Campbell S, Sun CL, Kurian S, Francisco L, Carter A, Kulkarni S, et al. Predictors of avascular necrosis of bone in long-term survivors of hematopoietic cell transplantation. Cancer. 2009;115(18):4127-35.
15. Socie G, Cahn JY, Carmelo J, Vernant JP, Jouet JP, Ifrah N, et al. Avascular necrosis of bone after allogeneic bone marrow transplantation: analysis of risk factors for 4388 patients by the Societe Francaise de Greffe de Moelle (SFGM). Br J Haematol. 1997; 97(4):865-70.
16. Armenian SH, Bhatia S. Cardiovascular disease after hematopoietic cell transplantation - lessons learned. Haematologica. 2008;93(8):1132-6.
17. Tichelli A, Passweg J, Wojcik D, Rovo A, Harousseau JL, Masszi T, et al. Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation. Haematologica. 2008;93(8):1203-10.
18. Tichelli A, Rovo A, Gratwohl A. Late pulmonary, cardiovascular, and renal complications after hematopoietic stem cell transplantation and recommended screening practices. Hematology Am Soc Hematol Educ Program. 2008;125-33.
19. Rovo A, Daikeler T, Stern M, Halter J, Studt JD, Buser A, et al. Physical and not mental health is impaired in very long-term survivors after HSCT compared with their respective donors: a paired analysis. Blood. 2008;111(3):1740-1.
20. McHorney CA, Ware JE Jr, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care. 1993;31(3): 247-63.
21. Ware JE Jr, Sherbourne CD. The MOS 36- item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473-83.
22. Baerlocher GM, Rovo A, Muller A, Matthey S, Stern M, Halter J, et al. Cellular senescence of white blood cells in very long-term survivors after allogeneic hematopoietic stem cell transplantation: the role of chronic graft-versus-host disease and female donor sex. Blood. 2009;114 (1):219-22.
23. Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant. 2005;11(12):945-56.
24. Choi M, Sun CL, Kurian S, Carter A, Francisco L, Forman SJ, et al. Incidence and predictors of delayed chronic kidney disease in long-term survivors of hematopoietic cell transplantation. Cancer. 2008; 113(7):1580-7.
25. Hingorani S, Guthrie KA, Schoch G, Weiss NS, McDonald GB. Chronic kidney disease in long-term survivors of hematopoietic cell transplant. Bone Marrow Transplant. 2007; 39(4):223-9.
26. Annaloro C, Usardi P, Airaghi L, Giunta V, Forti S, Orsatti A, et al. Prevalence of metabolic syndrome in long-term survivors of hematopoietic stem cell transplantation. Bone Marrow Transplant. 2008;41(9):797-804.
27. Taskinen M, Saarinen-Pihkala UM, Hovi L, Lipsanen-Nyman M. Impaired glucose tolerance and dyslipidaemia as late effects after bone-marrow transplantation in childhood. Lancet. 2000;356(9234):993-7.
28. Majhail NS, Flowers ME, Ness KK, Jagasia M, Carpenter PA, Arora M, et al. High prevalence of metabolic syndrome after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2009;43 (1):49-54.
29. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. J Am Coll Cardiol. 2004;44(3):720-32.
30. Koenig W, Lowel H, Baumert J, Meisinger C. C-reactive protein modulates risk prediction based on the Framingham Score: implications for future risk assessment: results from a large cohort study in southern Germany. Circulation. 2004;109(11): 1349-53.
31. Koenig W, Khuseyinova N, Baumert J, Meisinger C. Prospective study of high-sensitivity C-reactive protein as a determinant of mortality: results from the MONICA/KORA Augsburg Cohort Study, 1984-1998. Clin Chem. 2008;54(2):335-42.
32. Chen Z, Peto R, Collins R, MacMahon S, Lu J, Li W. Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations. BMJ. 1991;303(6797):276-82.
33. Tichelli A, Bucher C, Rovo A, Stussi G, Stern M, Paulussen M, et al. Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantation. Blood. 2007;110(9):3463-71.